ID: ALA2153731

Max Phase: Preclinical

Molecular Formula: C59H78N10O18

Molecular Weight: 1215.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCc2cccc3c2oc2c(cccc23)CCNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC1=O

Standard InChI:  InChI=1S/C59H78N10O18/c1-5-30(3)48-58(85)63-38(15-7-8-23-60)53(80)67-43(29-70)57(84)69-49(31(4)6-2)59(86)66-39(25-32-16-19-35(71)20-17-32)54(81)64-40(26-45(73)74)52(79)61-24-22-34-12-10-14-37-36-13-9-11-33(50(36)87-51(34)37)18-21-44(72)62-41(27-46(75)76)55(82)65-42(28-47(77)78)56(83)68-48/h9-14,16-17,19-20,30-31,38-43,48-49,70-71H,5-8,15,18,21-29,60H2,1-4H3,(H,61,79)(H,62,72)(H,63,85)(H,64,81)(H,65,82)(H,66,86)(H,67,80)(H,68,83)(H,69,84)(H,73,74)(H,75,76)(H,77,78)/t30-,31-,38-,39-,40-,41-,42-,43-,48-,49-/m0/s1

Standard InChI Key:  OLCSGGDIUGOCJQ-WYSFNPDNSA-N

Associated Targets(Human)

CD2 Tclin Lymphocyte function-associated antigen 3/T-cell surface antigen CD2 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1215.33Molecular Weight (Monoisotopic): 1214.5496AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Gokhale A, Weldeghiorghis TK, Taneja V, Satyanarayanajois SD..  (2011)  Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.,  54  (15): [PMID:21755948] [10.1021/jm200004e]

Source